Periprosthetic seromas and a third space effect after high-dose methotrexate
Wiener klinische Wochenschrift · 2025
DOI: 10.1007/s00508-024-02467-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiener klinische Wochenschrift, 2025. Verfasst von Claudia Prattes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Trauma, Medical University of Graz, Auenbruggerplatz 5, 8036, Graz, Austria. Hauptthemen laut MEDLINE: Methotrexate, Osteosarcoma, Seroma, Bone Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Graz.
Abstract (Originalsprache)
Background
Besides surgery, chemotherapy including high-dose methotrexate is a mainstay of osteosarcoma treatment. Methotrexate is known to accumulate in tissues and cavities, so-called third spaces (e.g., periprosthetic seromas) leading to local toxicity and delayed elimination (third space effect). We compared the concentrations of methotrexate in serum and periprosthetic seromas to evaluate a potential toxic risk based on a third space effect.
Methods
In 45 osteosarcoma patients who were treated with endoprosthesis and high-dose methotrexate (HDMTX) between 1991 and 2011 we retrospectively analyzed methotrexate concentrations in periprosthetic seromas and serum. Differences were assessed by means of the Wilcoxon test.
Results
A total of 112 periprosthetic seroma punctures were performed in 18 out of 45 patients. At 24 h the periprosthetic seroma concentrations were in median 14.86-fold (range 1.49–42.97-fold, p = 0.001), at 48 h in median 8.50-fold (range 1.36–52.56, p < 0.001) and at 72 h in median 2.66-fold (range 0.66–5.82, p = 0.015) of the corresponding serum concentrations. At 24 h highly toxic concentrations (≥ 20 μmol/l) were observed in 30% of all analyzed seromas (median 109.83 μmol/l, range 4.91–170.71 μmol/l). A significantly higher serum concentration (range 0.16–0.75 μmol/l, median 0.36 µmol/l) was found in patients with prior puncture than patients without puncture at 45 h after HDMTX.
Conclusion
Methotrexate concentrations of periprosthetic seromas are significantly higher than corresponding serum concentrations possibly contributing to a third space effect. To avoid severe adverse effects punctures of these effusions should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics and Trauma, Medical University of Graz, Auenbruggerplatz 5, 8036, Graz, Austria.
- Department of Orthopaedics and Trauma, Medical University of Graz, Auenbruggerplatz 5, 8036, Graz, Austria. andreas.leithner@medunigraz.at.
- Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
- Department of Anesthesiology, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria.
- Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Auenbruggerplatz 30, 8036, Graz, Austria.
Förderung
- Medical University of Graz
Zitieren
APA
Prattes, C., Leithner, A., Szkandera, J., Prattes, G., Urban, E. C., Eder-Halbedl, A., & Strenger, V. (2025). Periprosthetic seromas and a third space effect after high-dose methotrexate. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-024-02467-6
Vancouver
Prattes C, Leithner A, Szkandera J, Prattes G, Urban EC, Eder-Halbedl A, et al. Periprosthetic seromas and a third space effect after high-dose methotrexate. Wiener klinische Wochenschrift. 2025. doi:10.1007/s00508-024-02467-6
BibTeX
@article{Prattes2025,
author = {Prattes, Claudia and Leithner, Andreas and Szkandera, Joanna and Prattes, Georg and Urban, Ernst-Christian and Eder-Halbedl, Andrea and Strenger, Volker},
title = {Periprosthetic seromas and a third space effect after high-dose methotrexate},
journal = {Wiener klinische Wochenschrift},
year = {2025},
doi = {10.1007/s00508-024-02467-6}
}
EUVIMED